Stay updated with breaking news from Human Factors Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study paves the way toward a first-ever innovation program to include AI-optimization for FDA-guided Rx-to-OTC switch NEW YORK, NY / ACCESSWIRE / May 29, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI)
Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.
Shares of ReShape Lifesciences Inc. (NASDAQ:RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approv...
Petros Pharmaceuticals Successfully Completes Important Study in Effort ...
Q1 2023 Consolidated Revenue Grew 7%, Supported by 9% Growth in EGRIFTA SV® Revenue and 5% Growth in Trogarzo® Revenue Revised Sudocetaxel Zendusortide Phase 1 Trial... | April 12, 2023